Table 1 Patient characteristics
Total patient population | PS-matched patient population | ||||||
|---|---|---|---|---|---|---|---|
Total N = 822 | ENDOCLAMP N = 64 | EXOCLAMP N = 758 | p-value | ENDOCLAMP N = 63 | EXOCLAMP N = 63 | p-value | |
Age in years | 63.0 ± 12.1 | 62.3 ± 11.4 | 63.0 ± 12.2 | 0.675 | 62.2 ± 11.5 | 63.5 ± 13.1 | 0.554 |
Female gender, % | 42.3 | 39.1 | 42.6 | 0.581 | 39.7 | 34.9 | 0.581 |
BMI (kg/m2) | 26.2 ± 4.5 (570) | 27.2 ± 5.1 (41) | 26.1 ± 4.4 (529) | 0.133 | 27.3 ± 5.2 (40) | 25.9 ± 4.7 (53) | 0.179 |
CV risk factors | |||||||
Hypertension, % | 55.7 | 65.6 | 54.9 | 0.097 | 65.1 | 65.1 | 1.000 |
Dyslipidemia, % | 21.3 | 25.0 | 21.0 | 0.454 | 23.8 | 31.7 | 0.320 |
Diabetes mellitus, % | 7.3 | 15.6 | 6.6 | 0.020 | 14.3 | 14.3 | 1.000 |
Comorbidities general | |||||||
Creatinine (mg/dL) | 0.9 ± 0.3 | 0.9 ± 0.3 | 0.9 ± 0.3 | 0.977 | 0.9 ± 0.3 | 0.9 ± 0.5 | 0.114 |
Kidney failurea, % | 0.5 | 0.0 | 0.5 | 1.000 | 0.0 | 3.2 | 0.496 |
Stroke, % | 5.1 | 1.6 | 5.4 | 0.244 | 1.6 | 6.3 | 0.365 |
COPD, % | 11.9 | 14.1 | 11.7 | 0.582 | 14.3 | 19.0 | 0.473 |
PAD, % | 2.4 | 0.0 | 2.6 | 0.393 | 0.0 | 3.2 | 0.496 |
Comorbidity cardiac | |||||||
Atrial fibrillation, % | 31.5 | 32.8 | 31.4 | 0.815 | 31.7 | 38.1 | 0.455 |
Coronary artery disease, % | 7.7 | 18.8 | 6.7 | 0.002 | 17.5 | 19.0 | 0.818 |
Prior MI (≤ 90 days), % | 0.9 | 3.1 | 0.7 | 0.097 | 3.2 | 1.6 | 1.000 |
Prior AVR, % | 0.6 | 3.1 | 0.4 | 0.051 | 1.6 | 1.6 | 1.000 |
Prior CABG, % | 0.7 | 0.0 | 0.8 | 1.000 | 0.0 | 1.6 | 1.000 |
Prior pacemaker, % | 1.1 | 0.0 | 1.2 | 1.000 | 0.0 | 3.2 | 0.496 |
NYHA class III / IV, % | 68.5 | 65.6 | 68.7 | 0.612 | 65.1 | 66.7 | 0.851 |
CCS class III / IV, % | 2.2 | 0.0 | 2.4 | 0.388 | 0.0 | 6.3 | 0.119 |
Pulmonary hypertension, % | 14.0 | 10.9 | 14.2 | 0.463 | 11.1 | 17.5 | 0.309 |
Emergency indication, % | 4.5 | 9.4 | 4.1 | 0.061 | 7.9 | 7.9 | 1.000 |
LogEuroSCORE I, % | 3.1 [1.5–6.4] | 2.8 [1.5–5.5] | 3.1 [1.5–6.4] | 0.489 | 2.8 [1.5–5.5] | 3.5 [1.6–9.2] | 0.115 |